Literature DB >> 17214777

Comparative IFN-tau secretion after hatching by bovine blastocysts derived ex vivo and completely produced in vitro.

J A Neira1, D Tainturier, R M L'Haridon, J Martal.   

Abstract

The interferon-tau (IFN-tau) secretion levels after hatching by bovine blastocysts derived from in vitro maturated oocytes (Group A) and from in vivo (Group B) were investigated considering embryo quality. Only very homogeneous blastocysts of excellent or good quality were considered from day 7 of culture (Group A) and day 7 after artificial insemination with frozen-thawed from the same bull used for in vitro fertilization (Group B). All embryos were individually cultured into a 50 microl droplet of synthetic oviduct fluid medium with 10% fetal calf serum. After 24-h culture both Group A (n=44) and B (n=40) secreted <54 pm IFN-tau. After 48-, 72-, 96- and 120-h culture, Group A daily secreted 143 +/- 24 pm IFN-tau (n=19) vs 85 +/- 12 pm IFN-tau (n=21) for Group B (p < 0.01), 491 +/- 128 pm IFN-tau (n=29) vs 216 +/- 37 pm IFN-tau (n=23) (NS), 499 +/- 135 pm IFN-tau (n=26) vs 353 +/- 93 pm IFN-tau (n=21) (NS), 559 +/- 136 pm IFN-tau (n=22) vs 333 +/- 75 pm IFN-tau (n=20) (NS), respectively. Taken all together during 5 days, Group A produced per embryo 1690 +/- 290 pm IFN-tau (n=22) vs 982 +/- 182 pm IFN-tau (n=20) for Group B (p < 0.05). For all culture time there were sizable percentages of embryos that did not produce concentrations of IFN-tau above a certain cut-off level, and as such were not used to compute the means. In respect of the embryo quality whatever the groups after days 7-12 of culture, IFN-tau secretions were 1815 +/- 453 pm (n=10) for the embryos of excellent quality vs 1356 +/- 200 pm (n=28) for those of good quality (NS) and 360 +/- 188 pm (n=4) (p < 0.05) for embryos of fair quality. A positive relationship between IFN-tau production and in vitro development of quality I embryos was observed, whatever the embryos origins and, the embryos completely produced in vitro secreted more IFN-tau than the embryos produced in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17214777     DOI: 10.1111/j.1439-0531.2006.00732.x

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  5 in total

1.  Conceptus-derived prostaglandins regulate gene expression in the endometrium prior to pregnancy recognition in ruminants.

Authors:  Thomas E Spencer; Niamh Forde; Piotr Dorniak; Thomas R Hansen; Jared J Romero; Patrick Lonergan
Journal:  Reproduction       Date:  2013-08-21       Impact factor: 3.906

2.  The effects of 2,4-dinitrophenol and d-glucose concentration on the development, sex ratio, and interferon-tau (IFNT) production of bovine blastocysts.

Authors:  Mark P Green; Alexandra J Harvey; Lee D Spate; Koji Kimura; Jeremy G Thompson; R Michael Roberts
Journal:  Mol Reprod Dev       Date:  2015-10-21       Impact factor: 2.609

3.  IFN-τ Displays Anti-Inflammatory Effects on Staphylococcus aureus Endometritis via Inhibiting the Activation of the NF-κB and MAPK Pathways in Mice.

Authors:  Zhenbiao Zhang; Yingfang Guo; Yuzhu Liu; Chengye Li; Mengyao Guo; Ganzhen Deng
Journal:  Biomed Res Int       Date:  2017-02-26       Impact factor: 3.411

4.  Establishment of Trophectoderm Cell Lines from Buffalo (Bubalus bubalis) Embryos of Different Sources and Examination of In Vitro Developmental Competence, Quality, Epigenetic Status and Gene Expression in Cloned Embryos Derived from Them.

Authors:  Sushil Kumar Mohapatra; Anjit Sandhu; Karn Pratap Singh; Suresh Kumar Singla; Manmohan Singh Chauhan; Radheysham Manik; Prabhat Palta
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

5.  Effects of Extra-Long-Acting Recombinant Bovine FSH (bscrFSH) on Cattle Superovulation.

Authors:  Miguel A Gutiérrez-Reinoso; Constanza J Aguilera; Felipe Navarrete; Joel Cabezas; Fidel O Castro; Ignacio Cabezas; Oliberto Sánchez; Manuel García-Herreros; Lleretny Rodríguez-Alvarez
Journal:  Animals (Basel)       Date:  2022-01-09       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.